Literature DB >> 9371828

An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon.

A O Sousa1, J I Salem, F K Lee, M C Verçosa, P Cruaud, B R Bloom, P H Lagrange, H L David.   

Abstract

A survey of an emerging tuberculosis epidemic among the Yanomami Indians of the Amazonian rain forest provided a unique opportunity to study the impact of tuberculosis on a population isolated from contact with the tubercle bacillus for millennia until the mid-1960s. Within the Yanomami population, an extraordinary high prevalence of active tuberculosis (6.4% of 625 individuals clinically examined) was observed, indicating a high susceptibility to disease, even among bacille Calmette-Guérin-vaccinated individuals. Observational studies on cell-mediated and humoral immune responses of the Yanomami Indians compared with contemporary residents of the region suggest profound differences in immunological responsiveness to Mycobacterium tuberculosis infection. Among the Yanomami, a very high prevalence of tuberculin skin test anergy was found. Of patients with active tuberculosis, 46% had purified protein derivative of tuberculosis reactions <10 mm; similarly 58% of recent bacillus Calmette-Guérin vaccines exhibited skin test reactions <5 mm. The Yanomami also had higher titers of antibodies against M. tuberculosis glycolipid antigens (>70%) than the control subjects comprised of Brazilians of European descent (14%). The antibodies were mostly of the IgM isotype. Among the tuberculosis patients who also produced IgG antibodies, the titers of IgG4 were significantly higher among the Yanomami than in the control population. Although it was not possible to analyze T-cell responses or patterns of lymphokine production in vitro because of the remoteness of the villages from laboratory facilities, the results suggest that the first encounter of the Yanomami Indian population with tuberculosis engenders a diminished cell-mediated immune response and an increased production antibody responses, relative to other populations with extensive previous contact with the pathogen. These findings suggest that tuberculosis may represent a powerful selective pressure on human evolution that over centuries has shaped the nature of human immune responses to infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371828      PMCID: PMC24291          DOI: 10.1073/pnas.94.24.13227

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy.

Authors:  W L Salo; A C Aufderheide; J Buikstra; T A Holcomb
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

2.  Tuberculosis in Eskimos.

Authors:  S Grzybowski; K Styblo; E Dorken
Journal:  Tubercle       Date:  1976-12

3.  Cell-mediated immunity in anergic patients with pulmonary tuberculosis.

Authors:  D N McMurray; A Echeverri
Journal:  Am Rev Respir Dis       Date:  1978-11

4.  A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies.

Authors:  F K Lee; L Pereira; C Griffin; E Reid; A Nahmias
Journal:  J Virol Methods       Date:  1986-09       Impact factor: 2.014

5.  IgG subclass antibodies to herpes simplex virus.

Authors:  R M Coleman; A J Nahmias; S C Williams; D J Phillips; C M Black; C B Reimer
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

6.  Tuberculin test in retrospect and prospect.

Authors:  C E Palmer; L B Edwards
Journal:  Arch Environ Health       Date:  1967-12

7.  Restriction fragment length polymorphism analysis using IS6110 as an epidemiological marker in tuberculosis.

Authors:  I Otal; C Martín; V Vincent-Lévy-Frebault; D Thierry; B Gicquel
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

8.  World Health Organization studies on bacteriophage typing of mycobacteria. Subdivision of the species Mycobacterium tuberculosis.

Authors:  T A Rado; J H Bates; H W Engel; E Mankiewicz; T Murohashi; Y Mizuguchi; L Sula
Journal:  Am Rev Respir Dis       Date:  1975-04

9.  The intrinsic transmission dynamics of tuberculosis epidemics.

Authors:  S M Blower; A R McLean; T C Porco; P M Small; P C Hopewell; M A Sanchez; A R Moss
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

10.  Racial differences in susceptibility to infection by Mycobacterium tuberculosis.

Authors:  W W Stead; J W Senner; W T Reddick; J P Lofgren
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

View more
  37 in total

Review 1.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

2.  Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia.

Authors:  Julio C Delgado; Eunice Y Tsai; Sok Thim; Andres Baena; Vassiliki A Boussiotis; Jean-Marc Reynes; Sun Sath; Pierre Grosjean; Edmond J Yunis; Anne E Goldfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

3.  Negligible genetic diversity of mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure.

Authors:  J M Musser; A Amin; S Ramaswamy
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

4.  Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis.

Authors:  Liliana Encinales; Joaquin Zuñiga; Julio Granados-Montiel; Maria Yunis; Julio Granados; Ingrid Almeciga; Olga Clavijo; Carlos Awad; Vilma Collazos; María Inés Vargas-Rojas; José Luis Bañales-Mendez; Lilia Vazquez-Castañeda; Joel N Stern; Viviana Romero; Masha Fridkis-Hareli; Masha Frindkis-Hareli; Daniel Terreros; Marcelo Fernandez-Viña; Edmond J Yunis
Journal:  Mol Immunol       Date:  2009-12-09       Impact factor: 4.407

5.  Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans.

Authors:  Digna Rosa Velez; Christian Wejse; Martin E Stryjewski; Eduardo Abbate; William F Hulme; Jamie L Myers; Rosa Estevan; Sara G Patillo; Rikke Olesen; Alessandra Tacconelli; Giorgio Sirugo; John R Gilbert; Carol D Hamilton; William K Scott
Journal:  Hum Genet       Date:  2009-09-22       Impact factor: 4.132

6.  Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival.

Authors:  Susanne Homolka; Stefan Niemann; David G Russell; Kyle H Rohde
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

7.  Gene expression profiles of bronchoalveolar cells in pulmonary TB.

Authors:  Bindu Raju; Yoshihiko Hoshino; Ilana Belitskaya-Lévy; Rod Dawson; Stanley Ress; Jeffrey A Gold; Rany Condos; Richard Pine; Stuart Brown; Anna Nolan; William N Rom; Michael D Weiden
Journal:  Tuberculosis (Edinb)       Date:  2007-10-24       Impact factor: 3.131

8.  Both B-1a and B-1b cells exposed to Mycobacterium tuberculosis lipids differentiate into IgM antibody-secreting cells.

Authors:  Ciara Ordoñez; Hannah P Savage; Musharaf Tarajia; René Rivera; Cheyenne Weeks-Galindo; Dilcia Sambrano; Lee Riley; Patricia L Fernandez; Nicole Baumgarth; Amador Goodridge
Journal:  Immunology       Date:  2018-02-18       Impact factor: 7.397

9.  Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs.

Authors:  Loukia-Maria Mitsos; Lon R Cardon; Lynn Ryan; Ronald LaCourse; Robert J North; Philippe Gros
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

10.  IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB.

Authors:  Thorsten Thye; Edmund N Browne; Margaret A Chinbuah; John Gyapong; Ivy Osei; Ellis Owusu-Dabo; Norbert W Brattig; Stefan Niemann; Sabine Rüsch-Gerdes; Rolf D Horstmann; Christian G Meyer
Journal:  PLoS One       Date:  2009-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.